Background: Adiponectin (ADPN) levels are consistently elevated among patients with
advanced chronic kidney disease, but its relationship with cardiovascular outcomes in this …

Adiponectin has antidiabetic properties, and patients with obesity, diabetes, and insulin
resistance have low plasma adiponectin levels. However, although kidney disease is …

Adiponectin (ADPN), which is a secretory protein of adipose tissue, attenuates endothelial
inflammatory responses in vitro. Among human subjects, plasma ADPN concentrations are …

Background: Cardiovascular diseases resulting from atherosclerotic complications are major
causes of death in hemodialysis (HD) patients. Adiponectin (ADPN) is a recently discovered …

Aims: Adiponectin seems to be an important modulator for metabolic and vascular diseases.
We aimed to measure plasma adiponectin levels in type 2 diabetic patients and investigate …

Adiponectin is a multifunctional cytokine that has a role in regulating inflammation. In
patients without chronic renal failure (CRF) and type 2 diabetics, decreased adiponectin …

Patients with end-stage renal disease (ESRD) show an inverse association between body
mass index and risk of death from cardiovascular disease. Paradoxical epidemiology may …

Adiponectin is a protein secreted by adipose tissue. Unlike other adipocytokines produced
by adipose tissue, adiponectin appears to have anti-inflammatory, anti-diabetic, and anti …

Adiponectin is an adipocyte-specific cytokine that has a protective role in the development of
cardiovascular morbidities. As chronic kidney disease progresses, adiponectin levels …

Adiponectin is presumed to possess antiatherogenic and cardioprotective properties.
Limited data exist on the relationship between adiponectin and mortality in the earlier stages …